These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

183 related items for PubMed ID: 31560870

  • 21. Mass spectrometric determination of prostanoids in rat hypothalamic paraventricular nucleus microdialysates.
    Tachi M, Kondo F, Fukayama M, Yoshikawa K, Matsuura K, Okada S.
    Auton Neurosci; 2014 Apr; 181():49-54. PubMed ID: 24447364
    [Abstract] [Full Text] [Related]

  • 22. Selective corticotropin-releasing factor type 1 receptor antagonist blocks conditioned fear-induced release of noradrenaline in the hypothalamic paraventricular nucleus of rats.
    Otagiri A, Wakabayashi I, Shibasaki T.
    J Neuroendocrinol; 2000 Oct; 12(10):1022-6. PubMed ID: 11012844
    [Abstract] [Full Text] [Related]

  • 23. Effect of dexfenfluramine on the transcriptional activation of CRF and its type 1 receptor within the paraventricular nucleus of the rat hypothalamus.
    Laflamme N, Bovetto S, Richard D, Rivest S.
    Br J Pharmacol; 1996 Mar; 117(6):1021-34. PubMed ID: 8882592
    [Abstract] [Full Text] [Related]

  • 24. Prostaglandin E2 suppresses poly I: C-stimulated cytokine production via EP2 and EP3 in immortalized human corneal epithelial cells.
    Ueta M, Matsuoka T, Sotozono C, Kinoshita S.
    Cornea; 2012 Nov; 31(11):1294-8. PubMed ID: 22475642
    [Abstract] [Full Text] [Related]

  • 25. Intracerebroventricular administration of corticotropin-releasing factor antagonist attenuates c-fos mRNA expression in the paraventricular nucleus after stress.
    Imaki T, Shibasaki T, Wang XQ, Demura H.
    Neuroendocrinology; 1995 Apr; 61(4):445-52. PubMed ID: 7783858
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Nitric oxide stimulates ACTH secretion and the transcription of the genes encoding for NGFI-B, corticotropin-releasing factor, corticotropin-releasing factor receptor type 1, and vasopressin in the hypothalamus of the intact rat.
    Lee S, Kim CK, Rivier C.
    J Neurosci; 1999 Sep 01; 19(17):7640-7. PubMed ID: 10460269
    [Abstract] [Full Text] [Related]

  • 30. Excitatory stimulation of neurons in the arcuate nucleus initiates central CRF-dependent stimulation of colonic propulsion in rats.
    Tebbe JJ, Pasat IR, Mönnikes H, Ritter M, Kobelt P, Schäfer MK.
    Brain Res; 2005 Mar 02; 1036(1-2):130-8. PubMed ID: 15725410
    [Abstract] [Full Text] [Related]

  • 31. Changes in hypothalamic neurotransmitter and prostanoid levels in response to NMDA, CRF, and GLP-1 stimulation.
    Kondo F, Tachi M, Gosho M, Fukayama M, Yoshikawa K, Okada S.
    Anal Bioanal Chem; 2015 Jul 02; 407(18):5261-72. PubMed ID: 25633219
    [Abstract] [Full Text] [Related]

  • 32. Regulation of corticotropin-releasing factor and its types 1 and 2 receptors by leptin in rats subjected to treadmill running-induced stress.
    Huang Q, Timofeeva E, Richard D.
    J Endocrinol; 2006 Oct 02; 191(1):179-88. PubMed ID: 17065401
    [Abstract] [Full Text] [Related]

  • 33. Effect of acetylcholine on corticotropin-releasing factor gene expression in the hypothalamic paraventricular nucleus of conscious rats.
    Ohmori N, Itoi K, Tozawa F, Sakai Y, Sakai K, Horiba N, Demura H, Suda T.
    Endocrinology; 1995 Nov 02; 136(11):4858-63. PubMed ID: 7588217
    [Abstract] [Full Text] [Related]

  • 34. Acute alcohol administration stimulates the activity of hypothalamic neurons that express corticotropin-releasing factor and vasopressin.
    Rivier C, Lee S.
    Brain Res; 1996 Jul 08; 726(1-2):1-10. PubMed ID: 8836539
    [Abstract] [Full Text] [Related]

  • 35. Activation of corticotropin-releasing factor receptors in the rostral ventrolateral medulla is required for glucose-induced sympathoexcitation.
    Bardgett ME, Sharpe AL, Toney GM.
    Am J Physiol Endocrinol Metab; 2014 Nov 15; 307(10):E944-53. PubMed ID: 25269482
    [Abstract] [Full Text] [Related]

  • 36. Role of arginine vasopressin and corticotropin-releasing factor in mediating alcohol-induced adrenocorticotropin and vasopressin secretion in male rats bearing lesions of the paraventricular nuclei.
    Ogilvie KM, Lee S, Rivier C.
    Brain Res; 1997 Jan 02; 744(1):83-95. PubMed ID: 9030416
    [Abstract] [Full Text] [Related]

  • 37. Corticotropin-releasing factor activates c-fos, NGFI-B, and corticotropin-releasing factor gene expression within the paraventricular nucleus of the rat hypothalamus.
    Parkes D, Rivest S, Lee S, Rivier C, Vale W.
    Mol Endocrinol; 1993 Oct 02; 7(10):1357-67. PubMed ID: 8264665
    [Abstract] [Full Text] [Related]

  • 38. Effects of intravenous administration of interleukin-1-beta on the release of prostaglandin E2, corticotropin-releasing factor, and arginine vasopressin in several hypothalamic areas of freely moving rats: estimation by push-pull perfusion.
    Watanobe H, Takebe K.
    Neuroendocrinology; 1994 Jul 02; 60(1):8-15. PubMed ID: 8090286
    [Abstract] [Full Text] [Related]

  • 39. Mutual interactions of the presynaptic histamine H3 and prostaglandin EP3 receptors on the noradrenergic terminals in the mouse brain.
    Schlicker E, Marr I.
    Neuroscience; 1997 Jul 02; 79(1):247-54. PubMed ID: 9178880
    [Abstract] [Full Text] [Related]

  • 40. Corticotropin-releasing factor up-regulates its own receptor mRNA in the paraventricular nucleus of the hypothalamus.
    Imaki T, Naruse M, Harada S, Chikada N, Imaki J, Onodera H, Demura H, Vale W.
    Brain Res Mol Brain Res; 1996 May 02; 38(1):166-70. PubMed ID: 8737681
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.